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ABSTRACT 
Background: Breast cancer incidence in low and middle income countries continues to 
rise while outcomes remain poor. Early detection through screening has been recognized 
as an important factor for improving outcomes. Currently, there are no organized breast 
cancer screening programs in most low and middle income countries, Nigeria inclusive. 
In designing one, it is imperative to understand current screening practices, and barriers 
to screening. Also important, is the need to evaluate the prospects of a screening 
program given the limited resource capability and the possible impact of socio-cultural 
factors on the uptake of screening.  
Methods: Women, 40 years and older in Ife central and Iwo local governments in 
South-western Nigeria were surveyed. Ife central has a Teaching Hospital which offers 
mammography services while Iwo which is 32 miles away does not. Interviewers 
administered a 35 item questionnaire to assess socio-demographic information, breast 
cancer knowledge, mammography screening practices, reasons for not undergoing 
mammography and ability to pay for mammography. In addition, screening practices in 
the two communities were compared to assess the impact of access on uptake.  
As an initial step the prospects of a CBE based screening program in Ife-Central local 
Government was assessed. CBE practice as well as perceptions and preferences were 
evaluated. 
Results: 2222 women were interviewed, 1169(52.6%) in Ife and 1053(47.4%) in Iwo, 
most between ages 40-49 years. The majority had heard of breast cancer (Ife 94%, Iwo 
97%), but few were aware of mammography as a breast cancer screening tool (Ife 
  
11.8%, Iwo 11.4%). Mammography uptake in Ife was 2.8% and 1.8% in Iwo, despite 
Ife having mammography services geographically accessible and 20% reporting they 
could afford annual mammography at the present cost. Knowledge and practice of 
mammography were not statistically different between the two communities (p= 0.74, 
0.1). Lack of awareness was the reason for not undergoing mammography in the 
majority while only 20% reported they could afford annual mammography from both 
communities. 
Of the 1169 women in Ife, only 19.7% have had a CBE, of which only 6% had it in the 
last year. The majority (65.4%), were willing to have regular clinical breast examination 
and did not care about the gender of the examiner in most instances. Lack of perceived 
need was the reason cited by women unwilling to participate. 
Conclusion: Mammography screening practices are generally poor in spite of 
geographic access. Lack of awareness was cited as the principal barrier to screening, 
while cost may also be a potential limiting factor for many who are willing. 
With the majority willing to have regular CBE, a carefully designed CBE program 
coupled with advocacy to correct uneducated beliefs seems promising.
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ABSTRACT 
Background: Breast cancer incidence in low and middle income countries is rising 
while outcomes remain poor. Measures to promote early detection are therefore much 
required. This study evaluates barriers to mammography screening and examines the 
impact of geographic access to a mammography facility on screening uptake in two 
Nigerian communities.  
Methods: Women, 40 years and older in Ife central and Iwo local governments in 
Southwestern Nigeria were surveyed. Interviewers administered a 35 item questionnaire 
to assess socio-demographic information, breast cancer knowledge, mammography 
screening practices, reasons for not undergoing mammography and ability to pay for 
mammography. The two communities were compared.  
Results: 2222 women were interviewed, 1169 (52.6%) in Ife and 1053(47.4%) in Iwo, 
most between ages 40-49 years. Most had heard of breast cancer (Ife 94%, Iwo 97%), 
but few were aware of mammography as a breast cancer screening tool (Ife 11.8%, Iwo 
11.4%). Mammography uptake in Ife was 2.8% and 1.8% in Iwo, despite Ife having 
mammography services geographically accessible and 20% reporting they could afford 
annual mammography at the present cost. The knowledge and practice of 
mammography were not statistically different between the two communities (p= 0.74, 
0.1). Lack of awareness and lack of perceived need were the most common reasons for 
not undergoing mammography.  
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INTRODUCTION 
Breast cancer is more commonly diagnosed in high income countries; however, low and 
middle income countries (LMIC) report increasing incidence and higher mortality, a 
trend projected to continue over the next decades1. In Nigeria, breast cancer is the most 
common female malignancy2 and most women present with advanced diseases3-6, it is 
therefore not surprising that it is one of the leading causes of cancer death7.  
Breast cancer five year survival in Nigeria ranges from about 11-25% compared to 90% 
in the US8 9, 10 a difference attributed to widely available treatment and early detection 
through screening 11. In most low and middle income countries, radiation therapy and 
chemotherapy are not widely available or are unaffordable. Surgical treatment remains 
the most common treatment with chemotherapy, when affordable12, 13. Improving 
adjuvant treatment availability would be ideal; however, maximizing the benefit of 
surgical treatment through early diagnosis should be the initial focus given surgery is 
cheaper and more widely available14.  
Mammography while not widely available in Nigeria, can be found in cities and tertiary 
hospitals. Nigeria and other low resource countries report very low mammography 
uptake15-18. Cost may be a barrier19 given the fact that health costs in Nigeria are largely 
out of pocket with less than 5% of the population covered by the National Health 
Insurance Scheme20. Other factors are likely to contribute to poor mammography uptake 
given other forms of inexpensive or free screening demonstrate similarly poor uptake18, 
21. Reasons for poor mammography utilization in places with geographic access have 
not been comprehensively studied. These data are key to promoting screening. This 
study aims to determine the impact of geographic access on mammography uptake and 
to identify barriers to mammography uptake, in two communities in Southwestern 
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Nigeria, information essential for planning effective breast cancer screening and 
interventional programs. 
METHODS 
Study design and study population 
From February-April 2016, women 40 years and older were surveyed in Ife central and 
Iwo local government. The two communities are located in the Southwestern part of 
Nigeria, about 32 miles apart. Ife central local government is one of two local 
government areas in Ife, with a population of 167,254 people (2006 census figures). Ife 
has a University with an affiliated Teaching Hospital offering surgical and radiological 
services including mammography. Iwo with 191,348 people, also has a University, but 
only district hospitals without mammography services.  
The minimum required sample size of 1152 was calculated based on an estimated 3% 
mammography screening rate from a previous study at a confidence level at 95% and a 
margin of error set at 1% (0.01). Participants were women 40 years and older, selected 
from 15 wards in Iwo and 11 wards in Ife central local governments, using multistage 
sampling from the wards to the streets. Because of social characteristic variations all 
wards were sampled for equal representation. The number of women sampled from each 
ward was proportional to the fraction of the population the ward represented.  
Instrument 
A 35 item study specific interviewer administered questionnaire was utilized, first 
designed in English and later translated to Yoruba, the local language in Ife and Iwo, by 
a Yoruba language education expert. Pre-testing of 20 women in Ife was done in both 
languages with subsequent survey revision before final adoption. Ten minute interviews 
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were conducted by trained undergraduate and graduate students. Interviewers fluent in 
English and Yoruba had the questionnaire available in both languages with participants 
interviewed in their preferred language. The questionnaire gathered demographic 
characteristics, knowledge and experience about breast cancer, knowledge and practice 
of mammography, reasons for not undergoing mammography and other health 
behaviors.  
Key variables 
Study key variables were awareness of mammography, practice of mammography and 
reasons for not having mammography. Awareness of mammography was defined as 
knowledge of its existence as a breast cancer screening modality while practice of 
mammography was defined as having had a mammogram in the past. 
Statistical analysis 
Data was stratified based on location (Iwo and Ife) and descriptive statistics used to 
present socio-demographic characteristics, knowledge of breast cancer, practice of 
breast cancer screening and other key variables. Comparisons were made between Ife 
and Iwo based on the key outcome variables- awareness and practice of mammography 
using chi-square test.  
Factors associated with mammography uptake were assessed using simple and 
multivariate Poisson regression with robust variance estimation used to derive 
prevalence ratios with 95% confidence interval. Item selection for the multivariate 
regression was by backward elimination method in which a p-value of 0.25 was set as 
the level for removal from the model. 
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Ethics 
 Approval from the ethical committee of the Institute of public health of the Obafemi 
Awolowo University Ile-Ife and from Ife Central and Iwo Local government area 
authorities was obtained before survey administration. 
RESULTS 
2,222 women were interviewed, 1169 (52.6%) from Ife and 1053 (47.4%) from Iwo. 26 
women declined to be interviewed, for reasons such as their experience with breast 
cancer, fear of contracting cancer, lack of concern about it, or lack of time. 
Most participants were in their forties, with those from Ife slightly older than those from 
Iwo (Mean 49.13±10.45 years versus 47.95±8.79, Table 1). The majority had some form 
of education, with the largest percentage (819/2222, 36.9%) completing secondary 
education with a significant difference between those with primary and secondary 
education (p=0.01). Occupational distribution differed, however petty trading was the 
predominant occupation in both communities (Table 1). 
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Table 1.1: Socio-demographic characteristics 
 
     Ife 
(N =1169) 
             Iwo 
(N = 1053) 
     Total 
(N = 2222) 
 Freq. (%) Freq. (%)  Freq. (%) 
Age group     
40 – 49 687 (58.8) 652 (61.9)  1339 (60.3) 
50 – 59 266 (22.8) 261 (24.8)  527 (23.7) 
60 – 69 140 (12) 100 (9.5)  240 (10.8) 
>69 76 (6.5) 40 (3.8)  116 (5.2) 
Marital status     
Married 980 (83.8) 870 (82.6)  1850 (83.3) 
Single 15 (1.3) 15 (1.4)  30 (1.4) 
Widowed 150 (12.8) 131 (12.4)  281 (12.6) 
Separated 10 (0.9) 23 (2.2)  33 (1.5) 
Undisclosed   14 (1.2) 14 (1.3)  28 (1.3) 
Highest level of education   
None 182 (15.6) 180 (17.1)  362 (16.3) 
Primary 230 (19.7) 279 (26.5)  509 (22.9) 
Secondary 486 (41.6) 333 (31.6)  819 (36.9) 
College 256 (21.9) 255 (24.2)  511 (23) 
Not disclosed 15 (1.3) 6 (0.6)  21 (0.9) 
Occupation    
Artisans 74 (6.3) 46 (4.4)  120 (5.4) 
Traders 832 (71.2) 654 (62.1)  1486 (66.9) 
Farmers 45 (3.8) 57 (5.4)  102 (4.6) 
Civil servants 148 (12.6)           238 (22.6)  160 (17.4) 
Others 70 (6) 58 (5.6)  128 (5.8) 
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Awareness of breast cancer 
In both communities most women had heard of breast cancer (Table 2) although more 
in Iwo (97.2%) than Ife (94%) (p=0.001). Knowledge of someone with breast cancer 
was similar in both and the majority stated the persons they knew received medical 
treatment and had died (Table 2). 
Table 1.2: Knowledge and experience of breast cancer 
 Ife 
No (%) 
Iwo 
No (%) 
Total 
No (%) 
Have you ever heard of breast cancer?   
Yes  1099 (94) 1024 (97.2) 2123 (95.5) 
No 70(6) 29 (2.8) 99 (4.5) 
Do you know anyone who has had breast cancer?   
Yes  319 (27.3) 306 (29.1) 625 (28.1) 
No 850 (72.7)              747 (70.9) 1597 (71.9) 
Did the person receive medical 
treatment? 
         Ife 
(N=319) 
Iwo 
(N=306) 
Total 
(N=625) 
Yes 265(83.1) 246(80.4)             511 (81.8) 
No  15 (4.7) 14 (4.6) 29 (4.6) 
Don’t know 39 (12.2) 46 (15) 85 (13.6) 
What was the outcome in that person?   
Alive and well                                                                                
Alive but sick                                                                        
Dead  
Don’t know 
60 (18.7)
  32 (10)
207 (64.5)  
22 (6.9)                          
67 (21.9) 
38 (12.4) 
158 (51.6) 
43 (14.1) 
127 (20.3) 
70 (11.2) 
365 (58.2) 
65 (10.4) 
General health behavior 
The majority of women visit hospitals for healthcare, with a trend towards more 
hospitals visits in Iwo compared to Ife, (68.9% versus 63.8%, p=0.052).  
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Knowledge and practice of mammography screening  
Breast cancer screening of any type had been recommended to 37.2% of Ife and 36.6% 
of Iwo respondents; however, only 138 women (11.4%) from Ife and 120 women 
(11.6%) from Iwo had ever heard of mammography. Only 33 women (2.8%) from Ife 
and 19 women (1.8%) from Iwo had undergone mammography at any time, the majority 
not within the last year. Knowledge and practice of mammography screening did not 
differ between the two communities (Table 3). 
Table 1.3: Knowledge and practice of mammography 
  
Ife  
(N =1169)   
Iwo  
(N = 1053)   
Total  
(N = 2222)   p value 
  Freq. (%)   Freq. (%)   Freq. (%)     
Have you ever heard of mammography?        
Yes 138 (11.8)   120 (11.4)   258 (11.6)    
No 1031 (88.2)   933 (88.6)   1964 (88.4)   p = 0.764 
Have you ever had mammography?        
Yes 33 (2.8)   19 (1.8)   52 (2.3)    
No 1136 (97.2)   1034 (98.2)   2170 (97.7)   p = 0.113 
When did you last have mammography?          
Less than 1 year 7 (21.2)   4 (21.1)   11 (21.2)    
1 - 2 years 8 (24.2)   9 (47.4)   17 (32.7)    
Above 2 years 18 (54.5)   6 (31.6)   24 (46.2)   p = 0.187 
Do you know where mammography can be done?    
Yes 96 (69.6)   33 (27.5)   129 (50)    
No 42 (30.4)   87 (72.5)   129 (50)   p < 0.001 
How much does mammography cost?            
 Underestimated 18 (13)   14 (11.7)   32 (12.4)    
Correctly estimated 21 (15.2)   6 (5)   27 (10.5)    
Overestimated  4 (2.9)   6 (5)   10 (3.9)   p = 0.046 
Don’t know 95 (68.8)   94 (78.3)   189 (73.3)     
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Among those who had heard of mammography, a significantly higher number of women 
knew where mammography could be done in Ife (69.6%) compared to Iwo (27.5%, 
p<0.001). There were few women in both communities who correctly estimated the cost 
of mammography, 15.2% in Ife and 6% in Iwo (p=0.04). Poisson regression to 
determine factors associated with mammography screening showed that, practice of 
CBE (APR-6.36, p=<0.001) and knowledge of someone with breast cancer (APR-1.75, 
p=0.04), were associated with increased uptake.  
CBE is a screening modality available to both communities. More Iwo respondents 
reported having a CBE compared to Ife, 27.4% compared to 19.7%, (p<0.001).   Among 
those who had a CBE, 40.8% of Iwo and 30.4% of Ife respondents (p<0.001) had the 
exam in the last year 
Barriers to mammography screening 
Overall lack of awareness was the most common reason for not having mammography 
(76.7%) followed by lack of perceived need (15.9%). Other reasons given include 
challenges locating a mammography facility, obtaining an appointment, cost, fear of test 
results and embarrassment.  The same response pattern was observed in both 
communities (Figure 1). 
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Figure 1: Most important reason for not having done mammography 
Women were asked how much they could afford to pay for annual mammography. Of 
1350 responses from both communities, 20.4% could afford annual mammography at 
the current price, 12.7% at half the price, 19% less than half the price while 47.9% could 
afford nothing.   
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DISCUSSION 
Low and middle income countries face numerous barriers to quality health care 
including lack of facilities and resources22-24. While a challenge, the extent facility 
availability contributes to poor health indices may be exaggerated. It is imperative to 
understand factors affecting resource utilization, as examined in this study, to provide a 
rational basis for interventional program planning and help provide a foundation for 
optimal utilization of available health care facilities. This study shows poor utilization 
of mammography with poor awareness as the major contributing factor.   
Ife central and Iwo local governments are comparable communities given similar 
demographics. Our study shows the two communities demonstrate similar breast cancer 
knowledge, with similar percentages having heard about breast cancer and knowledge 
of someone who had the disease.  Our study depicts the personal experience of 
respondents: many they knew with breast cancer died despite medical care. This likely 
contributes to the belief that medical treatment offers little irrespective of disease extent. 
This belief affects patient attitudes toward early detection and must be addressed25. 
It is interesting to note that despite mammography service availability in Ife, 88.2% of 
Ife respondents were unaware of its existence. It is therefore not surprising that 
mammography uptake in Ife and Iwo were equally poor. This suggests that factors 
beyond geographic proximity contribute to low uptake.  This is further confirmed by 
the relatively few number of women who had a CBE, which surprisingly was higher in 
Iwo where specialized services do not exist. Our study did make us aware of a 
community wide breast cancer awareness and CBE campaign conducted by a Non-
Governmental Organization in Iwo General Hospital June 2013. This campaign may 
explain the higher Iwo CBE rates despite Ile-Ife having a teaching hospital with 
specialized breast care and more hospitals total.  
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In resource poor settings, many needs compete for funds. Given our results we 
recommend that breast cancer awareness and advocacy be given top priority in efforts 
against breast cancer. Community education and awareness programs should precede 
interventional programs aimed at increasing facilities to facilitate utilization of existing 
resources. Awareness campaigns should emphasize how stage at presentation affects 
breast cancer outcomes and the role of screening in early stage presentation. Awareness 
programs that feature testimonies from breast cancer survivors may be an effective 
approach to correct the erroneous belief that breast cancer always kills 26. Additionally, 
community education programs must address the lack of perceived breast cancer risk. 
This may require tailored approaches taking into account religious and cultural factors 
which underlie such beliefs27. 
 While creation of awareness and community outreach programs should be the starting 
point, sustainability for continued practice depends on breast cancer screening 
programs.  As in most LMIC, such programs do not exist in Nigeria 28. This deficiency 
contributes to poor screening rates and poor breast cancer outcomes.  
In developing a breast cancer screening program, various expert recommendations have 
been made which are applicable in Low and middle income countries, depending on 
available resources29-32. These recommendations, particularly at the basic and limited 
levels, can serve as a template to develop programs adaptable to each locality. The 
potential effect of cost is an important consideration in the development of any program. 
As awareness increases, other barriers such as cost may become more pressing33, 34. It 
will then be of no benefit creating awareness when financial access is not guaranteed. 
In this study, we assessed the potential impact of cost on mammography uptake by 
asking how much each respondent could afford for annual mammography. Although 
20% of respondents stated they could afford annual mammography at the current price, 
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it is striking that only 2.8% have had screening. A biennial screening program may 
improve affordability by decreasing overall cost; however there will remain many 
women requiring financial assistance to have mammography. Given the prevailing 
economic situation in most LMIC, this may not happen soon. As such there may be a 
need to selectively recommend mammography to high risk women who are most likely 
to benefit and advocate CBE for the majority of women. Successful CBE programs in 
certain LMICs provides a rational basis to consider its adoption35-37. A selective 
mammography screening program targeting women at high risk may create a demand 
more commensurate with screening services available to avoid overwhelming limited 
personnel and facilities38.  
We conclude that geographical access to a mammography screening facility has no 
influence on screening practices in the study population. Awareness and attitude are the 
most common reasons attributed to non-screening while cost is a potential limiting 
factor for some. An action plan to improve awareness and ensure optimal utilization of 
available resources with a carefully designed breast cancer screening program are 
urgently required.  
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CHAPTER TWO 
DEVELOPING A CLINICAL BREAST EXAMINATION BASED SCREENING 
PROGRAM IN A LOW INCOME COUNTRY; EVALUATING CURRENT 
PRACTICES, PERCEPTIONS AND POSSIBLE BARRIERS. 
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ABSTRACT 
Background: In low and middle-income countries (LMIC) like Nigeria, women present 
with advanced breast at an earlier age. Given the limited resources, development of 
screening programs that parallel resource capabilities of LMIC is imperative.  
Objective: To evaluate the perceptions, practices and barriers to clinical breast 
examination (CBE) screening in a low resource community in Nigeria. 
Methods: A cross-sectional survey of women, 40 years and above in Ife, South-West 
Nigeria using multi-staged sampling was performed. Information on socio-
demographics, knowledge of breast cancer, screening practices, and willingness to 
participate in CBE screening was obtained using an interviewer administered 
questionnaire. 
Results: A total of 1169 women whose ages ranged from 40-86 years with a mean age 
of 47.7± 8.79 years were interviewed. Of the 36% who had breast screening 
recommended to them previously, only 19.7% had an actual CBE. Of these only 6% 
had it in the last year. The majority (65.4%), were willing to have regular clinical breast 
examination and did not care about the gender of the examiner in most instances. Lack 
of perceived need was the reason cited by women unwilling to participate. 
Conclusion: The majority of women were aware of breast cancer and knew it as a fatal 
disease. With the relatively encouraging number of those willing to be examined, a 
carefully designed CBE program coupled with advocacy to correct uneducated beliefs 
seems promising. 
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INTRODUCTION  
Breast cancer is a common cause of cancer related deaths in most developing countries. 
Most cases presenting in advanced stages1, with high mortality2. Studies have shown a 
steady rise in the incidence of breast cancer in Nigeria from 15.3 per 100,000 in 1976 
to 33.6 per 100,000 in 1992 to 52.1 per 100,000 in 20123, 4. 
In developed countries however, mortality from breast cancer has been on the decline 
in spite of the higher incidence of breast cancer compared to low income countries5. 
This is due to the near equal contribution of early detection through screening and 
effective treatment modalities 6. Most developed countries have well organized breast 
cancer screening programs that recommend mammography on an annual or biennial 
basis for eligible women7, 8 . In the United States, women with average risk of breast 
cancer are recommended to undergo annual screening mammography starting at age 
45years up to age 54 years after which they should transition to biennial screening or 
continue screening annually. It is also recommended that women between ages 40 and 
44 years should have the opportunity to begin annual screening8. 
This has encouraged early presentation with concomitant improvement in outcomes 
compared to developing parts of the world9. The applicability of mammography based 
screening programs is however limited in low and middle income countries, due to the 
challenges of poor infrastructure, poverty and inadequate man power. Waiting until such 
capabilities are developed however, will lead to continued loss of life as a result of late 
presentation.  
CBE has therefore been recommended as a screening modality that may find usefulness 
in resource poor settings while efforts are underway to attain the status of international 
best practices. Studies of programs in Africa and India10-12 provide a strong rationale for 
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this assertion. The successes of these programs demonstrate the acceptability and 
feasibility for resource limited countries to develop formal programs at various levels 
of health care delivery that utilize clinical breast examination for screening either solely 
where mammography is unavailable or to complement mammography where it is in 
short supply.  
This should, however, be done cautiously, given previous experiences where most 
participants failed to comply with the screening recommendations after commencement 
of the program13. As a first step in developing such a program, it is imperative to 
understand the peculiarities of the target community in order to conduct a successful, 
socially acceptable and sustainable program. This study, conducted in a South-Western 
Nigerian community, set out to determine the perceptions, practices and possible 
barriers of clinical breast examination as a first step in developing a screening program 
in a low resource setting. 
METHODS 
Study population 
This study was conducted in the Ife central local government area of Osun State, South-
Western Nigeria between February and April 2016. Ife central local government is one 
of the two local governments in Ile-Ife, a city in south-western Nigeria. It has a 
population of 167,254 (2006 census figures). It has a teaching Hospital where 
specialized care, including breast services, are offered. 
The local government is made up of 11 wards, each having variable number of streets. 
Considerable variations exist in the social characteristics of the various wards, hence we 
sampled on all the wards for equal representation. Sampling was done using a multistage 
stratified sampling technique first into wards, and then into streets within each ward 
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across the local government, in order to obtain a representative sample of the entire 
community. The number sampled from each ward was proportional to the population 
size of the ward relative to the entire population. 
Women 40 years and above were eligible for this cross-sectional survey which assessed 
the practice of clinical breast examination and the possible barriers to a clinical breast 
examination based screening program in Ile-Ife. 
Instrument 
We utilized a study specific interviewer administered questionnaire for this study. It was 
first designed in English and later translated to Yoruba, which is the local language in 
Ile-Ife. Translation was done by a Yoruba language education expert. Pretesting was 
done using both English and Yoruba versions in a cohort of 20 women in Ile-Ife and 
this was reviewed before its final adoption for the study. Interviews were conducted by 
a team of undergraduate and graduate students who were trained prior to 
commencement of the study. They could effectively communicate in both English and 
Yoruba languages and each interviewer had a copy of the questionnaire in both 
languages. Participants were interviewed based on their language preferences. Each 
interview lasted an average of 10 minutes. The questionnaire gathered information on 
demographic characteristics, knowledge and experience about breast cancer, practice of 
clinical breast examination, willingness to participate in a CBE program and possible 
barriers to participating in such a program.  
Key variables 
The key variables in this study were practice of clinical breast examination, willingness 
to participate in a regular clinical breast examination based program and reasons for 
refusal to participate. 
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We employed two measures of practice of CBE which are: ‘practice of CBE ever’ and 
‘practice of CBE in the last one year’. Multiple responses were allowed for reasons for 
not having had CBE of which the most important according to each respondent was 
taken as the main reason for having not undergone CBE.  
Statistical analysis 
Socio-demographic characteristics, awareness of breast cancer, practice of breast cancer 
screening, willingness to participate in Clinical Breast Examination screening and other 
key variables were analyzed using descriptive statistics. Simple and multivariate 
Poisson regression with robust variance estimation was used to derive prevalence ratios 
with 95% confidence interval for the assessment of factors associated with willingness 
to participate in CBE. Variables selected for the multivariate Poisson regression was by 
backward stepwise elimination method with a p-value of 0.25 set as the level for 
removal from the model. Data analysis was done using STATA version 12. 
Ethics  
 This study was approved by the ethical committee of the Institute of Public Health of 
the Obafemi Awolowo University Ile-Ife and approval was also obtained from the Ife 
Central Local government authority before the survey was conducted. 
RESULTS 
Sociodemographic characteristics  
A total of 1169 women were surveyed across the entire local government. Their ages 
ranged from 40 to 86 years with a mean age of   47.7± 8.79 years. Most of the 
respondents had some form of education with only 15.6% having no formal education 
at all. Most were married and were traders as shown in Table 2.1. 
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Table 2.1: Socio-demographic characteristics 
    (N=1169) 
 Freq         % 
Age group   
40 – 49 687       58.8 
50 – 59 266       22.8 
60 – 69 140       12.0 
>69 76        6.5 
Marital status                                
Married 980      83.8 
Widowed  150      12.8 
Single 15      1.3 
Separated 10       .9 
Undisclosed 14      1.2 
 
Highest education level                                                   
None 182 15.6 
Primary 230 19.7 
Secondary 486 41.6 
College graduate 256 21.9 
Undisclosed 15 1.3 
 
Occupation                                                            
Artisans 74 6.3 
Traders 832 71.2 
Farmers 45 3.8 
Civil servants/Professionals 148 12.6 
Others 83 7.1 
Religion   
Christianity 876 74.9 
Islam 281 24.0 
Others 12 1.0 
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Knowledge and Experience of breast cancer 
Most of the respondents (94%) had heard about breast cancer, while 27.5% knew 
someone who has had the disease. Amongst these, 82.5% claimed the persons they knew 
had received treatment in the hospital, and about two-thirds had died from the disease 
(Table 2.2). 
Table 2.2: Knowledge of Breast Cancer 
Have you ever heard of breast cancer?  No  % 
Yes 1099 94.0 
No 70 6.0 
Do you know anyone who has had breast cancer    
Yes 321 27.5 
No 848 72.5 
Did the person receive medical treatment?   
Yes 265 82.5 
No 15 4.7 
Don't know 41 12.8 
Total 321 100 
What was the outcome in that person?    
Dead  207 64.5 
Alive and well 60 18.7 
Alive but sick 32 10 
Don't know 22 6.8 
Total 321 100 
Do you think breast cancer can be cured medically?   
Yes 482 41.2 
No 209 17.9 
Don't know 478 40.9 
General health behavior  
Assessment of their general health behavior shows that, about two thirds of the 
respondents receive treatment for their health challenges in the hospital (63.9%), while 
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the others either self-medicate (19.2%), visit medicine stores (9.2%) or patronize 
herbalists (3.7%).  Other health behaviors assessed include blood sugar test which had 
ever been done by only 42.8% while the remaining 57.2% have never had a blood sugar 
check. Pap smear for cervical cancer screening was done by 10.8% of the women while 
the majority (89.2%) have never had a pap smear. 
Breast cancer screening practice  
Specifically, with regards to breast cancer screening, the majority of women have never 
been screened by any method. Only 37.7% of the respondents had ever had breast cancer 
screening recommended to them. Of these, screening was recommended by a health 
worker in 43% of cases, mass media (37.8%), friends and relatives (13.6%), or religious 
and public seminars (5.6%). Regular self-breast examination was practiced by 31.2% of 
the women, while 23.5% claim to examine their breasts irregularly and 45.3% do not 
examine their breasts at all. 
There were only 230 women (19.7%) who have ever had their breast examined by a 
health practitioner at any time. When asked when they last had such examination, only 
6% of the 19% have had it in the last 1 year, 4.4% within the last two years and 9.2% 
have not had it in over 2 years.  
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Table 2.3: Breast cancer screening practices 
 Freq. % 
Anyone recommended any method of early detection to you?   
Yes 441 37.7 
No 728 62.3 
How regularly do you examine your breasts?   
Monthly  365 31.2 
Irregularly  275 23.5 
Never 529 45.3 
Ever had breast examined by a health practitioner(CBE)   
Yes 230 19.7 
No 939 80.3 
When was the last time you had CBE   
Within the last one year 70 6 
More than 1 year 160 13.7 
Never had a CBE 939 80.3 
Attitude towards CBE screening programme 
With regards to willingness to participate in a regular breast examination programme, 
765(65.4%) of the respondents were willing to participate in a regular breast 
examination screening programme while 404 (34.6%) were not. Lack of perceived need 
was the reason given for non-willingness by those who declined. Preference for gender 
of the examiner was sought and 249 (32%) would prefer a female examiner, 15 women 
(2%) preferred a male examiner while the majority (65.5%) do not care about the gender 
of the examiner. This was the case regardless of religion and level of education (p=0.63, 
0.3 respectively). Prevalence ratio derived from Poisson regression with robust estimate 
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of variance showed that willingness to participate in CBE was significantly higher 
among women who were civil servants (APR-1.21, p-<0.001), who knew someone who 
had breast cancer (APR-1.15, p value-<0.001)), who practice regular SBE (APR-1.22, 
p-<0.001) and those who have had pap smear (APR-1.20, p-<0.001).  
DISCUSSION 
The current reality regarding the pattern of breast cancer presentation in most Low and 
middle income countries is disturbing.  What is more worrisome, however, is the lack 
of an organized effort to control this trend. While the economic implications of adopting 
breast cancer standards are daunting, it is no excuse for the minimal efforts to date.  
The use of clinical breast examination has been considered a surrogate for the standard 
screening modality in economically deprived countries and has been shown to produce 
good results5. As a means of translating this into practice, we embarked on this study to 
obtain necessary information that may assist in developing a viable, culturally 
acceptable screening programme. Our findings show that CBE uptake, though poor is 
acceptable to the majority of the women with very little social concerns. 
Most of the respondents, who are women in their 40s, represent the population most 
affected by breast cancer in Nigeria and indeed most black populations1.  While 
mammography is generally recommended in most instances for women above 40 years, 
its benefit in terms of survival for women less than 50 years is controversial. 14, 15. As 
such, adopting a clinical breast examination based programme may not be out of place, 
at least until capabilities are developed for routine mammography. The fact that 94% of 
the respondents have heard about breast cancer is indeed a testimony to the relatively 
frequent occurrence of breast cancer in our society. What one wonders however, is the 
kind of knowledge that is entrenched in the social network, considering the fact that a 
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vast majority of those who knew someone with breast cancer, majority of whom 
received treatment in the hospital, claimed the persons they knew had died from the 
disease. The fact that less than half of the respondents believe breast cancer can be cured 
medically further solidifies the notion that is perhaps most widely believed about breast 
cancer which is that of uncertainty about its outcome or that of an invariably fatal disease 
irrespective of treatment. While most deaths are due to late presentation, they are usually 
attributed to failed treatment, thus perpetuating the idea that death is the inevitable 
consequence of breast cancer regardless of time of presentation or treatment. This is an 
aspect of community education that must be strongly addressed during awareness 
campaigns. Improvements in the outcome of breast cancer treatment will however be 
the most convincing evidence to correct this misconception. 
With barely a third of women having ever had any form of breast cancer screening 
recommended to them, it is clear little is being done with regard to public advocacy.  It 
is therefore not surprising that less than one fifth have ever had a clinical breast 
examination. In addition, the majority of these women had not been examined in the 
last year. Health workers certainly have a major role to play in creating breast cancer 
awareness and making screening recommendations to their contacts. As shown in this 
study, the majority of the recommendations were made by health workers. Contacts 
made with health personnel during visits to the hospital for various health challenges, 
can be utilized as a means of creating awareness and for opportunistic clinical breast 
examination screening. A link can also be created between breast health programs and 
other primary health programs such as maternal and child health services thereby 
utilizing such existing platforms for screening. This leverages on already existing 
infrastructure without creating a separate programme that requires mobilization of 
resources specifically for breast cancer. This is a cost effective design in resource 
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constrained settings where the incidence of breast cancer is not high enough for a cancer 
detection rate that justifies the investment of huge amount of resources on a vertical 
programme. Such an approach has also been favored by other breast cancer experts16. 
Combination of breast and cervical cancer screening is another approach that can be 
utilized as a cost effective and more comprehensive screening programme for women. 
This has also been successfully practiced with some good results11. Training of 
personnel to effectively carry out breast examinations is key to the success of such a 
program, and this has been demonstrated by interventional programs that have utilized 
such model11, 17. Nurses and midwives, who make regular contacts with women have 
been suggested as ideal personnel to carry out such examinations16.  
Although known to be relatively inexpensive without any requirement for technology, 
a CBE screening program will nevertheless require funding for training and other 
running costs. The relatively lower cost compared to other more expensive technology 
dependent screening modalities may however serve as a basis for lobbying policy 
makers to incorporate it into the Health Insurance Scheme in countries where such 
programs exist. 
The success of any screening program ultimately depends on the number of women who 
eventually get treated among those who screen positive. This can be enhanced by 
developing an effective referral system for diagnosis and treatment. A very encouraging 
treatment completion rate of 92% was observed in a randomized controlled trial of 
breast and cervix cancer screening in India where such referral system was in place11. 
The concept of patient navigation which was first described by Harry Freeman in 1990 
in the United States has also continued to find more relevance in promoting prompt 
diagnosis and treatment of screen positive women. It is a patient-centered health-care 
service delivery model that assists individuals, particularly the medically underserved, 
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in overcoming personal, logistical, and system barriers to care across the cancer care 
continuum18, 19. A similar concept may also be of benefit in low and middle income 
countries where access to health care constitutes a challenge.    
The role of the media also features prominently in this study as an important means of 
creating awareness. Its wide coverage and the peculiar advantage of reaching those who 
do not regularly visit hospitals makes it a very attractive medium for creating breast 
cancer awareness. The various social and religious platforms that allows for information 
sharing also provide additional opportunities for advocacy which should be explored.  
The breast being a private area of the body, and the fact that there are various social, 
religious and cultural considerations that must be considered when planning 
interventional programs, it is important to seek the opinion of the target population about 
such interventions and about possible obstacles. This is particularly important as 
approximately 99% of women ascribed to some religious affiliation. It is encouraging 
that more than two thirds of the respondents are willing to have regular breast 
examination.  Responses from those who declined such examination suggests that with 
proper education and enlightenment, many more are likely to be won over, given that 
the reasons for  non-willingness border on  lack of perceived need for the test. Such 
perceptions are probably based on the misconception of the essence of screening, as a 
test meant only for those who know they have the disease. It should therefore not be 
assumed that the concept of screening is clearly understood by all, and should feature 
prominently during public enlightenment campaigns.  
Bearing in mind the impact of culture and religion on such an intervention, we sought 
to know if there are preferences for the gender of the examiner. It is quite interesting to 
note that the majority do not care about the gender of the examiner as long as 
competence is guaranteed. This was the case irrespective of age group, level of 
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education or religion. This finding was also observed in a study from Southern Nigeria 
which evaluated, amongst other things the impact of gender of the examiner on breast 
screening practices20. This finding may however not be generalizable bearing in mind 
the concept of hidden socio-cultural and religious barriers. As such, it is recommended 
that early detection programs be implemented alongside educational programs which 
aid acceptance, coupled with modifications that are culturally appropriate to the 
region21. 
From the foregoing, the number of women who visit hospitals for various health 
challenges allowing opportunities for contact with a trained health personnel, provides 
a great opportunity for breast cancer advocacy and screening. A hospital based 
screening programme can therefore be designed to target such groups. Even if the 
detection rate is low, minimal resources would be expended, while awareness would 
have been created. Those who do not visit hospitals regularly, who constitute the 
minority of the women studied, may then be reached through community outreach 
programs.   
The willingness of women to have a breast examination without much social concerns 
and the negligible cost of CBE, altogether make a carefully designed programme look 
promising. In addition to creating an opportunity for early detection, it also serves as a 
means of improving the general health seeking behavior of the populace which certainly 
creates the necessary ground work for optimal utilization of standard screening 
modalities and facilities when they become widely available. 
In conclusion, our findings show that current CBE practice though poor, is acceptable 
to the majority of women in the studied population with few social concerns. Awareness 
creation with educational programs are needed to correct erroneous perceptions about 
breast cancer and the need for screening 
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APPENDIX 
SURVEY INSTRUMENT 
BREAST SCREENING PRACTICES IN NIGERIA 
We are asking for your permission for participation in a survey on breast cancer 
screening. Please answer the following questions. 
Where do you live? (Please check one): Ile-Ife ☐  Iwo ☐ 
SECTION A: GENERAL KNOWLEDGE AND EXPERIENCE ABOUT 
BREAST CANCER 
1. Have you ever heard of breast cancer? 
a. Yes    ☐        b. No☐ 
2. Do you know anyone who has had breast cancer? 
a. Yes ☐          b. No ☐ 
3.  What was your relationship with the person? ____________________________ 
 
4. Did the person receive medical treatment?  
            a. Yes ☐ b. No ☐ c. Don’t know ☐ 
5. What was the outcome in that person?  
                  a. Alive and well ☐  
            b. Alive but sick ☐  
                  c. Don’t know ☐  
            d. Not applicable ☐  
 
6. Do you think breast cancer is curable? 
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a. Yes ☐        b. No  ☐     c. Don’t know ☐ 
7. Do you think breast cancer can be cured medically? 
a. Yes ☐         b. No  ☐      c. Don’t know ☐ 
(If No, Please state the method of treatment you think offers cure) 
___________________________________ 
8. Do you think breast cancer can be detected early? 
a. Yes   ☐     b. No  ☐     
9. Has anyone ever recommended any method of early detection to you? (Mention 
who) 
a. Yes    ☐    b. No   ☐ 
10. Please mention the methods of early detection you are aware of: 
_______________________________________________ 
SECTION B: MAMMOGRAPHY  
11. Have you ever heard of mammography? 
a. Yes ☐        b. No ☐ 
12. What is mammography? 
a. It is a blood test ☐ 
b. It is a urine test   ☐ 
c. It is a form of X-ray of breast ☐ 
d. Don’t know ☐ 
13. Who should have mammography? 
a. Teenage girls ☐ 
b. Women in their twenties ☐ 
c. Women in their thirties ☐ 
d. Women forty years and above ☐ 
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e. Only elderly women ☐ 
f. Don’t know ☐ 
14. How frequently should mammography be done? 
a. Once in a life time ☐ 
b. Every 1 to 2 years ☐ 
c. Once in 5 years ☐ 
d. Every 10 years ☐ 
e. Don’t know ☐ 
15. Do you know where mammography can be done in your town? 
a. Yes ☐       b. No ☐     c. Don’t know ☐ 
16. How much does mammography cost? 
a. <5,000 ☐ 
b. 5,000-10,000 ☐ 
c. >10,000 Naira ☐ 
d. Don’t know ☐ 
17. If the test were recommended for you as a means of preventing death from breast 
cancer, what is the maximum amount you can afford once a year to do the test? 
_____________________________________________________ 
18. When did you last have mammography? 
a. <1 year ☐ 
b. 1-2 years ☐ 
c. >2 years ☐ 
d. Never ☐ 
19. What would you say is/are the reason(s) why you have not had a mammography 
before? 
a. Don’t know about the test ☐ 
39 
 
b. Don’t know where to do the test ☐ 
c. Nobody has told me the importance of the test ☐ 
d. Difficult to get an appointment  ☐ 
e. I don’t have the money to do the test  ☐ 
f. Too busy to do the test ☐ 
g. Feel embarrassed to do the test  ☐ 
h. Worried about what the test might show  ☐ 
i. Don’t think I need the test  ☐ 
j. Others (please specify)  
_______________________________________________________________
_______________________________________________________________ 
 
 
20. Which of these is the most important reason why you have not had 
mammography? 
________________________________________________ 
SECTION C: CLINICAL BREAST EXAMINATION 
21. Have you ever had your breast examined by a health practitioner? 
a. Yes     ☐   b. No ☐ 
22. When was the last time you had such examination? 
a. <6months    ☐ 
b. 6-12 months ☐ 
c. 1-2 years ☐ 
d. >2 years ☐ 
e. Never  ☐ 
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23.  If recommended as a means of early detection and prevention of unnecessary 
death from breast cancer, will you be willingly to have a health practitioner 
examine your breast once in 6 months? 
a. Yes ☐         b. No ☐ 
24. If No why? _________________________________________________ 
25. Who will you prefer to examine you? 
a. Male practitioner ☐    b. Female practitioner ☐    c. Don’t care about the gender ☐ 
SECTION D: SELF BREAST EXAMINATION AND OTHER HEALTH 
BEHAVIOURS 
26. How regularly do you examine your breasts? 
a. At least once a month ☐   b. At Once in 2-6 months ☐ c. Once in 7-12 
months ☐    d. Rarely ☐         e. Never ☐ 
 27. Where do you commonly receive treatment when you have health challenges? 
a. Traditional healers ☐ 
b. Patent medicine stores  ☐ 
c. Hospitals   ☐ 
d. Self-medication  ☐ 
e. Others (please specify)  
_________________________________________________________
_________________________________________________________ 
28. Which of the following tests have you ever done? 
a. Pap smear ☐ 
b. Blood sugar test ☐ 
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SECTION E: PLEASE GIVE US A LITTLE INFORMATION ABOUT 
YOURSELF 
29. Please tell us your age: _________________________ 
30. What is your marital status? 
    a. Married ☐    b.  Single ☐    c. Widowed ☐   d. Separated ☐ 
31. Which of the following best describes your level of education 
a. None ☐ 
b. Primary☐ 
c. Secondary ☐ 
d. College graduate ☐ 
32. Which of the following best describes the level of education of your husband? 
a. None ☐ 
b. Primary ☐ 
c. Secondary ☐ 
d. College graduate ☐ 
e. Not applicable  ☐ 
33. What is your occupation? 
a. Farming ☐ 
b. Trading  ☐ 
c. Teaching/Lecturing  ☐ 
d. Government employee   ☐ 
e. Artisan  ☐ 
f. Others(Please specify)   ________________ 
34. What is the occupation of your husband? 
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a. Farming ☐ 
b. Trading ☐ 
c. Teaching/Lecturing ☐ 
d. Government employee ☐ 
e. Artisan ☐ 
f. Others (Please specify) _________________ 
35. What is your religion? 
a. Christianity 
b. Islam 
c. Traditional worship 
d. Others (Please specify) 
 
Thank you for participating in this study. 
 
 
 
